Bulletin
Investor Alert

ALX Oncology Holdings Inc.

NAS: ALXO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 14, 2022, 4:00 p.m.

/zigman2/quotes/219511930/composite

$

18.50

Change

0.00 0.00%

Volume

Volume 5,985

Quotes are delayed by 20 min

/zigman2/quotes/219511930/composite

Previous close

$ 18.43

$ 18.50

Change

+0.07 +0.38%

Day low

Day high

$17.05

$18.82

Open

52 week low

52 week high

$17.05

$89.04

Open

Annual Financials for ALX Oncology Holdings Inc.

Fiscal year is January-December. All values USD millions. 201820192020 5-year trend
Sales/Revenue --2.07M4.8M1.18M
Cost of Goods Sold (COGS) incl. D&A --1.88M4.36M1.08M
COGS excluding D&A --1.45M3.93M873,000
Depreciation & Amortization Expense --431,000429,000202,000
Depreciation --431,000429,000202,000
Amortization of Intangibles -----
Gross Income --187,000436,000107,000
201820192020 5-year trend
SG&A Expense --13.87M19.62M43.77M
Research & Development --11.27M16.31M28.96M
Other SG&A --2.6M3.31M14.81M
Other Operating Expense -----
Unusual Expense ----1.15M
EBIT after Unusual Expense ----(44.81M)
Non Operating Income/Expense --(2,000)(5,000)120,000
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense ---21,000811,000
Gross Interest Expense ---21,000811,000
Interest Capitalized -----
Pretax Income --(13.69M)(19.21M)(45.5M)
Income Tax --45,00034,000241,000
Income Tax - Current Domestic --1,0001,000241,000
Income Tax - Current Foreign --44,00033,000-
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income --(13.73M)(19.24M)(45.74M)
Minority Interest Expense -----
Net Income --(13.73M)(19.24M)(45.74M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries --(13.73M)(19.24M)(45.74M)
Preferred Dividends --3.67M4.03M5.2M
Net Income Available to Common --(17.4M)(23.27M)(50.94M)
EPS (Basic) --(0.48)(0.64)(1.28)
Basic Shares Outstanding --36.49M36.49M39.84M
EPS (Diluted) --(0.48)(0.64)(1.28)
Diluted Shares Outstanding --36.49M36.49M39.84M
EBITDA --(13.25M)(18.75M)(43.46M)
Trending Tickers
  • /zigman2/quotes/208747069/composite GEVO+7.77%
  • /zigman2/quotes/228313454/composite CNTX+0.36%
  • /zigman2/quotes/214140886/composite CHPT+5.01%
  • /zigman2/quotes/208173073/composite SFIX+4.61%
  • /zigman2/quotes/222642382/composite OLMA+5.43%
X
Powered by StockTwits
Link to MarketWatch's Slice.